| Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459) |
|---|
| 04/21/2005 | US20050085517 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
| 04/21/2005 | US20050085512 Amides that inhibit vanilloid receptor subtype 1 (VR1) receptor |
| 04/21/2005 | US20050084463 Antiinflammatory, antiarthritic agents, analgesics for pain caused by diabetic assoicated conditions, pneumoconiosis, angina, menstruation or cancer |
| 04/21/2005 | CA2540978A1 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups |
| 04/21/2005 | CA2535930A1 Inhibitors of cathepsin s |
| 04/20/2005 | EP1524267A1 Substituted benzylaminoalkylene heterocycles |
| 04/20/2005 | EP0984947B1 Oxazolidinone antibacterial agents having a thiocarbonyl functionality |
| 04/20/2005 | CN1608050A Piperazine derivative |
| 04/19/2005 | US6881735 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/19/2005 | US6881727 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 04/14/2005 | WO2005033056A2 Triphenylethylene compounds as selective estrogen receptor modulators |
| 04/14/2005 | US20050080269 Process for the preparation of 1,2-dichloroethane free crystals of zonisamide |
| 04/14/2005 | US20050080119 Diaminopropionic acid derivatives |
| 04/14/2005 | US20050080118 Pharmaceuticals for the treatment of rejection reactions in organ transplantations |
| 04/14/2005 | US20050080106 Such as 2-[3,5-Di(2-chlorobenzyloxy)benzoyl)amino]-thiazole; for treatment of diabetes |
| 04/14/2005 | US20050079979 Substituted benzoylisoxazoles and the use thereof as herbicides |
| 04/13/2005 | EP1257270B1 A method for synthesizing leflunomide |
| 04/13/2005 | EP1242416B1 Substituted isoxazolines and their use as antibacterial agents |
| 04/12/2005 | US6878743 Controlling apoptosis; central nervous system disorders |
| 04/07/2005 | WO2005030738A1 Improved process for the preparation of intermediates useful for the preparation of zonisamide |
| 04/07/2005 | WO2005019147A3 Pesticidally active phenol derivatives |
| 04/07/2005 | US20050075383 Inhibitors of phophodiesterase type-IV |
| 04/07/2005 | US20050075379 5-(ester-substituted benzyl or benzylidene)-thiazolidine-2,4-diones; readily metabolized by the physiological metabolic drug detoxification systems without loss of therapeutic benefit; lower side effects and toxicity in patients with elevated or compromised liver function |
| 04/07/2005 | US20050075323 Beta3 adrenergic receptor agonists and uses thereof |
| 04/06/2005 | EP1519915A2 Tricyclic steroid hormone nuclear receptor modulators |
| 04/06/2005 | EP1077700B1 BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF IgE |
| 04/06/2005 | EP0748219B1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/06/2005 | CN1195734C Phthalamide derivs., intermediates in production thereof, and agricultural/horticultural insecticides and method of using same |
| 04/05/2005 | US6875780 Compounds that modulate PPAR activity and methods for their preparation |
| 04/05/2005 | US6875768 Phthalamide derivatives, intermediates in the production thereof, and agricultural/horticultural insecticides and method for using the same |
| 03/31/2005 | WO2004098591A3 Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases |
| 03/31/2005 | US20050070581 such as 3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-methoxybenzylidene-2,4-thiazolidinedione; Hodgkin's disease |
| 03/31/2005 | US20050069912 Energy transfer dyes with enhanced fluorescence |
| 03/30/2005 | EP1517899A1 Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors |
| 03/30/2005 | EP1517898A1 Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseases |
| 03/30/2005 | EP1517897A2 Benzimidazole compounds and their use as estrogen agonists/antagonists |
| 03/30/2005 | EP1444197B1 Novel phenyl-propargylether derivatives |
| 03/30/2005 | EP0980369B1 Sulfonamides for treatment of endothelin-mediated disorders |
| 03/30/2005 | CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 03/29/2005 | US6872851 Melatonergic receptors; antiinflammatory agents; anticancer agents |
| 03/29/2005 | CA2261760C Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 03/29/2005 | CA2217169C Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
| 03/24/2005 | WO2005026133A1 Isoxazoles as peptide deformylase inhibitors |
| 03/24/2005 | WO2005012220A3 Cycloalkylidene compounds as modulators of estrogen receptor |
| 03/24/2005 | WO2005005389A3 Malonamide derivatives |
| 03/24/2005 | WO2004080925A3 Synthesis of tetrahydro-1,2-oxazines by the cycloaddition of nitrones with cyclopropanes |
| 03/24/2005 | WO2004072101A3 Phenylglycine derivatives useful as serine protease inhibitors |
| 03/24/2005 | US20050065095 Antibacterial agents |
| 03/23/2005 | EP1516877A1 Amine derivatives as protease inhibitors |
| 03/23/2005 | CN1597668A Biamido heterocyclic derivative with antitumour activity and its preparation method and use |
| 03/22/2005 | US6869969 Isoxazole estrogen receptor agonist and antagonist |
| 03/22/2005 | US6869953 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents |
| 03/22/2005 | CA2225250C Bicyclic amino derivatives and pgd2 antagonist containing the same |
| 03/17/2005 | WO2005023759A2 Heterocyclic inhibitors of mek and methods of use thereof |
| 03/17/2005 | WO2005023247A1 Compounds and methods |
| 03/17/2005 | US20050059810 Dibenzylamine compound and medicinal use thereof |
| 03/17/2005 | US20050059729 Substituted cyclic compounds |
| 03/17/2005 | US20050059714 2-Cyclopropyl-4-(5-fluoro-2-methoxyphenyl)-4-methyl-1-(1H-pyrrolo[2,3-c]pyridin-2-yl)pentan-2-ol; treating diseases of inflammatory, allergic, or proliferative condition; type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumor |
| 03/17/2005 | CA2537321A1 Heterocyclic inhibitors of mek and methods of use thereof |
| 03/16/2005 | EP1513817A1 1, 2-azole derivatives with hypoglycemic and hypolipidemic activity |
| 03/16/2005 | EP0874625B1 Indane derivatives for antipsychotic compositions |
| 03/16/2005 | CN1596240A Chalcone derivatives and their use to treat diseases |
| 03/10/2005 | WO2005021536A2 Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as dpp-iv inhibitors |
| 03/10/2005 | WO2005021516A1 Caspase inhibitors containing isoxazoline ring |
| 03/10/2005 | WO2005021515A2 Inhibitors of phosphodiesterase type-iv |
| 03/10/2005 | WO2005020899A2 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity |
| 03/10/2005 | WO2005007620A3 New n-hydroxy-4-(3-phenyl-5-methyl-isoxazole-4-yl)-benzenesulfonamide solvates |
| 03/10/2005 | WO2004103278A3 Acyl sulfonamides as inhibitors of hiv integrase |
| 03/10/2005 | WO2004096795A3 C-fms kinase inhibitors |
| 03/10/2005 | US20050054701 Heterocyclic inhibitors of MEK and methods of use thereof |
| 03/10/2005 | US20050054637 Prophylaxis, therapy cardiovascular disorders |
| 03/10/2005 | US20050054626 Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity |
| 03/10/2005 | CA2537185A1 Inhibitors of phosphodiesterase type-iv |
| 03/10/2005 | CA2537123A1 New compounds |
| 03/09/2005 | EP1511473A2 Bis-aromatic alkanols |
| 03/09/2005 | EP1216125B1 A homogenization enhancing thermoplastic foam extrusion screw |
| 03/09/2005 | CN1592735A Novel alpha-oxygenated or alpha-thiolated carboxylic acid phenethylamide derivatives |
| 03/09/2005 | CN1592616A GABA enhancers in the treatment of diseases relating to reduced neurosteroid activity |
| 03/03/2005 | WO2005019212A1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 03/03/2005 | WO2005019184A1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 03/03/2005 | WO2005019174A1 Acetylene derivatives as inhibitors of histone deacetylase |
| 03/03/2005 | WO2005019151A1 Ppar modulators |
| 03/03/2005 | WO2005019147A2 Pesticidally active phenol derivatives |
| 03/03/2005 | WO2004063166A8 Heterocyclic ppar modulators |
| 03/03/2005 | WO2004001058A3 Transcription factor modulating compounds and methods of use thereof |
| 03/03/2005 | US20050049419 Heterocyclic inhibitors of MEK and methods of use thereof |
| 03/03/2005 | DE10336186A1 Sulfonamid-Anionen als Katalysatoren für die NCO-Oligomerisierung Sulfonamide anions as catalysts for the NCO oligomerization |
| 03/03/2005 | CA2536089A1 Ppar modulators |
| 03/03/2005 | CA2535350A1 Acetylene derivatives as inhibitors of histone deacetylase |
| 03/02/2005 | EP1509497A1 Calcium receptor modulating arylalkylamines |
| 03/02/2005 | EP1509491A1 Intermediate products, methods for their preparation and use thereof |
| 03/02/2005 | EP1278741B1 Muscarinic agonists |
| 03/02/2005 | EP1066250B1 A convergent synthesis of alpha-aryl-beta ketonitriles |
| 03/02/2005 | CN1191063C Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders |
| 02/24/2005 | WO2005017037A1 Sulphonamide anions as catalysts for nco oligomerisation |
| 02/24/2005 | WO2005016862A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | US20050042771 Identifying non-drug targets; use in drug design for improving knowledge of drug-target and drug-non-target interactions, so that drug adverse reactions can be reduced or eliminated in drugs such as troglitazone, rosiglitazone, pioglitazone, methotrexate, atorvastatin, celecoxib, rofecoxib, cerivastatin |
| 02/24/2005 | CA2535665A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | CA2534850A1 Sulphonamide anions as catalysts for nco oligomerisation |
| 02/23/2005 | EP1507777A2 Process for preparing crystalline form i of cabergoline |